Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020)
Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi
Glycobiology, 2020
SNFG,
Text,
Oxford
taxonomy (1)
protein (1)
source (1)
structure (0)
composition (49)
disease (1)
reference (1)
site (17)
peptide (80)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- HEK293 (CVCL_0045)
Source
Reported structure
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2776.5561 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2647.4406 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FSNVTWF (7aa)
- HAIHVSGTNGTKRF (14aa)
- HAIHVSGTNGTKRFDNPVLPF (21aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- LIVNNATNVVIKVCEF (16aa)
- TQSLLIVNNATNVVIK (16aa)
- SLLIVNNATNVVIK (14aa)
- IVNNATNVVIKVCEF (15aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- HKNNK (5aa)
- SALEPLVDLPIGINITRFQTL (21aa)
- SALEPLVDLPIGINITR (17aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITRFQTLL (22aa)
- SALEPLVDLPIGINITRF (18aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- VQPTESIVR (9aa)
- RVQPTESIVRFPNITNLCPFGEVF (24aa)
- VQPTESIVRFPNITN (15aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- GEVFNATR (8aa)
- GEVFNATRF (9aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSP (35aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSN (60aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTEC (59aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEIL (36aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSM (40aa)
- SIIAYTMSLGAENSVAYSN (19aa)
- AYSNNSIAIPTNFTISVTTEILPVSMTK (28aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (43aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGS (68aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIA (80aa)
- SNNSIAIPTNFTISVTTEILPVSMTK (26aa)
- TNFTISVTTEILPVSMTK (18aa)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
- NFTISVTTEILPVSMTK (17aa)
- IPTNFTISVTTEILPVSMTK (20aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQL (72aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- NFSQILPDPSKPS (13aa)
- NFSQILPDPSKPSKR (15aa)
- NFNFSQILPDPSKPSKR (17aa)
- NFSQILPDPSKPSK (14aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
- VPAQEKNFTTAPA (13aa)
- NFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQ (33aa)
- VPAQEKNF (8aa)
- VTYVPAQEKNFTTAPAICHDGK (22aa)
- VVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (32aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- NFTTAPAICHDGKAHFPR (18aa)
- NFTTAPAICHDGKA (14aa)
- VPAQEKNFTTAPAICH (16aa)
- NFTTAPAICHDGK (13aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- NFTTAP (6aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDG (40aa)
- PAQEKNFTTAPAICHDGKAHFPR (23aa)
- GVFVSNGTHWFVTQR (15aa)
- AHFPREGVFVSNGTHWFVT (19aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE (53aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (55aa)
- EGVFVSNGTHWFVTQRN (17aa)
- EGVFVSNGTHWF (12aa)
- AHFPREGVFVSNGT (14aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP (54aa)
- VSNGTHWFVTQR (12aa)
- EGVFVSNGTHWFVTQRNFYEPQIITT (26aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDN (28aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS (37aa)
- AHFPREGVFVSNGTHW (16aa)
- EGVFVSN (7aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (50aa)
- EGVFVSNGTHWFVTQR (16aa)
- NLNESLIDLQELGK (14aa)
- NLNESLIDLQELGKYEQYIK (20aa)
Mass spectrometry observed peptide
-
- Hex:3 HexNAc:3 / N-Linked
(avg mass : 1114.0275)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TNFTISVTTEILPVSMTK (18aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIA (80aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (55aa)
- EGVFVSNGTHWFVTQRN (17aa)
- EGVFVSNGTHWFVTQR (16aa)
- AHFPREGVFVSNGT (14aa)
-
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FSNVTWF (7aa)
- HAIHVSGTNGTKRF (14aa)
- HAIHVSGTNGTKRFDNPVLPF (21aa)
- SLLIVNNATNVVIK (14aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- IVNNATNVVIKVCEF (15aa)
- SALEPLVDLPIGINITRFQTL (21aa)
- SALEPLVDLPIGINITRF (18aa)
- SALEPLVDLPIGINITR (17aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITRFQTLL (22aa)
- VQPTESIVRFPNITN (15aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- RVQPTESIVRFPNITNLCPFGEVF (24aa)
- GEVFNATRF (9aa)
- GEVFNATR (8aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSN (60aa)
- AYSNNSIAIPTNFTISVTTEILPVSMTK (28aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (43aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEIL (36aa)
- SNNSIAIPTNFTISVTTEILPVSMTK (26aa)
- NFTISVTTEILPVSMTK (17aa)
- AHFPREGVFVSNGTHWFVT (19aa)
- EGVFVSNGTHWFVTQR (16aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP (54aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGS (68aa)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
- VPAQEKNF (8aa)
- VVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (32aa)
-
- Hex:3 HexNAc:4 / N-Linked
(avg mass : 1317.2225)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNFTTAPA (13aa)
- VSNGTHWFVTQR (12aa)
- EGVFVSNGTHWFVTQR (16aa)
- AHFPREGVFVSNGTHW (16aa)
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- GEVFNATRF (9aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSM (40aa)
- SIIAYTMSLGAENSVAYSN (19aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMT (41aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQL (72aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1422.3129)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNF (8aa)
-
- Hex:5 HexNAc:3 / N-Linked
(avg mass : 1438.3123)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- DLPQGFSALEPLVDLPIGINITR (23aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- HAIHVSGTNGTKRF (14aa)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- GEVFNATRF (9aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- VPAQEKNF (8aa)
- NFTTAPAICHDGKA (14aa)
- VPAQEKNFTTAPAICH (16aa)
-
- Hex:4 HexNAc:4 / N-Linked
(avg mass : 1479.3649)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQRNFYEPQIITT (26aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:3 HexNAc:5 / N-Linked
(avg mass : 1520.4175)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSN (7aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVS (37aa)
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FSNVTWF (7aa)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- SALEPLVDLPIGINITRF (18aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTEC (59aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1584.4553)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NSIAIPTNFTISVTTEILPVSMTK (24aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- RVQPTESIVRFPNITNLCPF (20aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- VPAQEKNF (8aa)
- PAQEKNFTTAPAICHDGKAHFPR (23aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDG (40aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:3 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1666.5605)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
-
- Hex:4 HexNAc:5 / N-Linked
(avg mass : 1682.5599)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- HKNNK (5aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FSNVTWF (7aa)
- LIVNNATNVVIK (12aa)
- SLLIVNNATNVVIK (14aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- LIVNNATNVVIKVCEF (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- GEVFNATRF (9aa)
-
- Hex:3 HexNAc:6 / N-Linked
(avg mass : 1723.6125)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IPTNFTISVTTEILPVSMTK (20aa)
- GVFVSNGTHWFVTQR (15aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL (50aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWF (12aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE (53aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1770.6228)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSP (35aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- NFSQILPDPSKPS (13aa)
- VTYVPAQEKNFTTAPAICHDGK (22aa)
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SALEPLVDLPIGINITR (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- NFTTAPAICHDGK (13aa)
- NFTTAPAICHDGKAHFPR (18aa)
-
- Hex:5 HexNAc:5 / N-Linked
(avg mass : 1844.7023)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
-
- Hex:3 HexNAc:6 dHex:1 / N-Linked
(avg mass : 1869.7555)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAP (6aa)
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LIVNNATNVVIK (12aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- NFSQILPDPSKPSK (14aa)
- NFSQILPDPSKPS (13aa)
- NFNFSQILPDPSKPSKR (17aa)
- NFTTAP (6aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- NFSQILPDPSKPSK (14aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- NFSQILPDPSKPS (13aa)
- NFSQILPDPSKPSKR (15aa)
- NFNFSQILPDPSKPSKR (17aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
-
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQ (33aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- SALEPLVDLPIGINITR (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2485.2982)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNFTTAPAICHDGK (19aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
-
- Hex:6 HexNAc:6 NeuAc:1 / N-Linked
(avg mass : 2501.2976)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2518.3251)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNFTTAPAICHDGK (19aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2647.4406)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNFTTAPAICHDGK (19aa)
-
- Hex:7 HexNAc:6 NeuAc:1 / N-Linked
(avg mass : 2663.44)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:5 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2776.5561)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YNENGTITDAVDCALDPLSETK (22aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2792.5555)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2809.583)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDN (28aa)
-
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2954.6979)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YNENGTITDAVDCALDPLSETK (22aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 3100.8409)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YNENGTITDAVDCALDPLSETK (22aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked
(avg mass : 3245.9558)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EGVFVSNGTHWFVTQR (16aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3392.0988)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YNENGTITDAVDCALDPLSETK (22aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked
(avg mass : 3683.3567)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YNENGTITDAVDCALDPLSETK (22aa)
- NLNESLIDLQELGK (14aa)
- NLNESLIDLQELGKYEQYIK (20aa)
-
- Hex:1 HexNAc:1 / O-Linked
(avg mass : 383.3527)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VQPTESIVR (9aa)
-
- Hex:1 HexNAc:1 NeuAc:2 / O-Linked
(avg mass : 965.8685)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VQPTESIVR (9aa)
-
- Hex:2 HexNAc:2 NeuAc:1 / O-Linked
(avg mass : 1039.948)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VQPTESIVR (9aa)
-
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked
(avg mass : 1331.2059)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VQPTESIVR (9aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 NeuAc:2 / O-Linked
(avg mass : 1331.2059)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 NeuAc:1 / O-Linked
(avg mass : 1039.948)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:1 NeuAc:2 / O-Linked
(avg mass : 965.8685)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:1 HexNAc:1 / O-Linked
(avg mass : 383.3527)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 / N-Linked
(avg mass : 3683.3567)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3392.0988)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked
(avg mass : 3245.9558)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 3100.8409)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked
(avg mass : 3026.7614)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2954.6979)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2809.583)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked
(avg mass : 2792.5555)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2776.5561)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 NeuAc:1 / N-Linked
(avg mass : 2663.44)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2647.4406)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2518.3251)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 NeuAc:1 / N-Linked
(avg mass : 2501.2976)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2485.2982)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:1 / N-Linked
(avg mass : 1869.7555)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 / N-Linked
(avg mass : 1844.7023)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1770.6228)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 / N-Linked
(avg mass : 1723.6125)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 / N-Linked
(avg mass : 1682.5599)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1666.5605)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1584.4553)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:5 / N-Linked
(avg mass : 1520.4175)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 / N-Linked
(avg mass : 1479.3649)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:3 / N-Linked
(avg mass : 1438.3123)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1422.3129)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 / N-Linked
(avg mass : 1317.2225)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 / N-Linked
(avg mass : 1114.0275)